Gut Bacteria May Predict Risk of Life-Threatening Infections Following Chemotherapy

Study could help physicians choose care path for some cancer patients

Brought to you byUniversity of Minnesota
| 3 min read
Register for free to listen to this article
Listen with Speechify
0:00
3:00

A new study led by researchers at the University of Minnesota and Nantes University Hospital in France shows that the bacteria in people’s gut may predict their risk of life-threatening blood infections following high-dose chemotherapy.

The study was published Apr. 28 in Genome Medicine, a peer-reviewed open access journal.

About 20,000 cancer patients receive high-dose chemotherapy each year in preparation for bone marrow or stem cell transplants. Typically about 20 to 40 percent develop blood infections following the chemotherapy. Sadly, about 15-30 percent of those patients die as a result of the infections.

To continue reading this article, sign up for FREE to
Lab Manager Logo
Membership is FREE and provides you with instant access to eNewsletters, digital publications, article archives, and more.
Add Lab Manager as a preferred source on Google

Add Lab Manager as a preferred Google source to see more of our trusted coverage.

Related Topics

Current Magazine Issue Background Image

CURRENT ISSUE - October 2026

Why Lab Teams Resist Change—And How Leaders Can Respond

Addressing the human side of automation, AI, and operational change

October 2026 Lab Manager Cover Image